Definitive 3D-CRT for clinically localized prostate cancer: modifications of the clinical target volume following a prostate MRI and the clinical benefits
Open Access
- 15 July 2015
- journal article
- research article
- Published by Springer Nature in SpringerPlus
- Vol. 4 (1) , 347
Abstract
To evaluate the modifications of the tumor stage and clinical target volume following a prostate magnetic resonance imaging (MRI) to evaluate the tumor (T) staging, and the clinical benefits for prostate cancer. A total of 410 patients with newly diagnosed and clinically localized prostate cancer were retrospectively analyzed. The patients were treated with definitive three-dimensional conformal radiotherapy (3D-CRT). In all of the patients, digital rectal examination, transrectal ultrasound, prostate biopsy and computed tomography were performed to evaluate the clinical stage. Of the 410 patients, 189 patients had undergone a prostate MRI study to evaluate the T staging, and 221 patients had not. Modification of the T stage after the prostate MRI was seen in 39 (25%) of the 157 evaluable patients, and a modification of the risk group was made in 14 (9%) patients. Eventually, a modification of the CTV in 3D-CRT planning was made in 13 (8%) patients, and 10 of these had extracapsular disease. Most of the other modifications of the T staging were associated with intracapsular lesions of prostate cancer which did not change the CTV. There were no significant differences in the biological relapse-free survival between the patients with and without a prostate MRI study. Modification of the CTV were recognized in only 8% of the patients, most of whom had extracapsular disease, although that of the T stage was seen in approximately one-quarter of the patients. Prostate MRI should only be selected for patients with a high probability of extracapsular involvement.Keywords
This publication has 29 references indexed in Scilit:
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate CancerEuropean Urology, 2011
- Australian & New Zealand Faculty of Radiation Oncology Genito‐Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinomaJournal of Medical Imaging and Radiation Oncology, 2010
- Comparison of Phased-Array 3.0-T and Endorectal 1.5-T Magnetic Resonance Imaging in the Evaluation of Local Staging Accuracy for Prostate CancerJournal of Computer Assisted Tomography, 2007
- Per-Sextant Localization and Staging of Prostate Cancer: Correlation of Imaging Findings with Whole-Mount Step Section HistopathologyAmerican Journal of Roentgenology, 2007
- Prostate Cancer: Detection of Extracapsular Extension by Genitourinary and General Body Radiologists at MR ImagingRadiology, 2004
- Prostate Cancer: Incremental Value of Endorectal MR Imaging Findings for Prediction of Extracapsular ExtensionRadiology, 2004
- Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis.Radiology, 1997
- Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging.American Journal of Roentgenology, 1996
- Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (thermotron RF-8) in combination with radiation for cancer therapyCancer, 1986